InvestorsHub Logo
Replies to #94043 on Biotech Values
icon url

genisi

04/13/10 9:54 AM

#94044 RE: DewDiligence #94043

I didn't like the Globes piece and changed the post to the Mersana PR. Have another look.
icon url

genisi

01/03/11 1:51 PM

#111819 RE: DewDiligence #94043

In a convention last week, Teva’s CFO said the comp. is looking for big branded acquisitions in the range of $2B-$8B, in cancer, neurology and immunology arenas.